search indicatorNeed Help?

Books by Subject

Substance-Related DisordersAccess restricted to Stanford unless otherwise noted

  • The Principles of addiction medicine / Duncan Raistrick -- Substitute prescribing : opioid-specific prescribing / Kim Wolff -- Substitute prescribing : buprenorphine maintenance prescribing / Nick Lintzeris -- Treatment of withdrawal symptoms / Joanna Banbery -- Replacement prescribing / Kim Wolff -- Management of comorbidity / Duncan Raistrick -- Toxicologic issues / Kim Wolff -- Medical aspects of drug abuse / Shoshana Zevin and Neal L. Benowitz -- Emergency management of drug abuse / Brett A. Roth, Neal L. Benowitz, and Kent R. Olson.
  • Addiction medicine 2011, Springer
    This book attempts to "bridge the gap between the explosion of neuroscientific and behavioral knowledge in the past three decades and treatment delivery in clinical practice. As such, it should fulfill the role of a comprehensive textbook that integrates addiction medicine from its scientific underpinnings to the treatment of patients in clinical settings"--Preface, p. vii.
  • Addiction Recovery Management: Theory, Research, and Practice is the first book on the recovery management approach to addiction treatment and post-treatment support services. Distinctive in combining theory, research, and practice within the same text, this ground-breaking title includes authors who are the major theoreticians, researchers, systems administrators, clinicians and recovery advocates who have developed the model. State-of-the art and the definitive text on the topic, Addiction Recovery Management: Theory, Research, and Practice is mandatory reading for clinicians and all professionals who work with patients in recovery or who are interested in the field.
  • "While there is a wealth of published information on addiction medicine, the psychological aspects of alcohol abuse, and behavioral medicine with regard to addiction, virtually none of the existing resources were written with the primary care provider in mind. Addressing Unhealthy Alcohol Use in Primary Care is a handy reference for primary care clinicians who are confronted by patients with these problems daily, and who wish to successfully address these issues in their practice. Focusing on the literature and science relevant to practicing providers, this book covers the range of interventions appropriate for this setting. Topics include assessment, brief counseling interventions, pharmacotherapy, referrals to both specialty care and Alcoholics Anonymous (and other self-help programs), psychiatric comorbidity and other drug use, and other information specific to the needs of the primary care clinician. The vast majority of people with health risks and consequences related to alcohol use receive little to no attention from healthcare, despite the fact that alcohol is a leading cause of early preventable death. This book is a guide to identifying and addressing unhealthy alcohol use in hopes of improving the lives of patients."--publisher's website
  • 1A Selected Social History of the Stepping-Stone Drugs /Thomas P. Gullotta1 --2A Biological/Genetic Perspective: The Addicted Brain /Thomas H. Kelly, Alessandra N. Kazura, Karen M. Lommel, Shanna Babalonis, Catherine A. Martin15 --3Individual Characteristics and Needs Associated with Substance Misuse of Adolescents and Young Adults in Addiction Treatment /Michael L. Dennis, Michelle K. White, Melissa L. Ives45 --4Adolescent Substance Abuse Treatment: A Review of Evidence-Based Research /Ken C. Winters, Andria M. Botzet, Tamara Fahnhorst, Randy Stinchfield, Rachel Koskey73 --5Adolescent Outpatient Treatment /Richard Dembo, Randolph D. Muck97 --6Evidence-Based Family Treatment of Adolescent Substance Abuse and Dependence /Shaun I. Calix, Mark A. Fine119 --7Residential Treatment of Adolescents with Substance Use Disorders: Evidence-Based Approaches and Best Practice Recommendations /Robert W. Plant, Peter Panzarella135 --8Primary Prevention in Adolescent Substance Abuse /Martin Bloom, Thomas P. Gullotta155 --9Religious Involvement and Adolescent Substance Use /Terrence D. Hill, Amy M. Burdette, Michael L. Weiss, Dale D. Chitwood171 --10School Prevention /Zili Sloboda191 --11Community Prevention Handbook on Adolescent Substance Abuse Prevention and Treatment: Evidence-Based Practices /Elizabeth J. D'Amico, Matthew Chinman, Stefanie A. Stern, Abraham Wandersman213 --Epilogue: The Status of Knowledge Development and the Unknown /Michele Staton-Tindall, Thomas P. Gullotta, William Walton Stoops, Carl G. Leukefeld251.
  • Advances in animal models of relapse for addiction research / Friedbert Weiss -- Application of chronic extracellular recording method to studies of cocaine self-administration : method and progress / Laura L. Peoples, Alexai V. Kravitz, and Karine Guillem -- Neurochemistry of addiction : monitoring essential neurotransmitters of addiction / Stefan G. Sandberg and Paul A. Garris -- Alcohol craving and relapse prediction : imaging studies / Andreas Heinz ... [et al.] -- Integrating behavioral and molecular approaches in mouse : self-administration studies / Danielle L. Graham and David W. Self -- Neuroeconomics : implications for understanding the neurobiology of addiction / Michael L. Platt ... [et al.].
  • Alcohol and cancer 2011, Springer
  • Alcohol and tobacco 2011, Springer
  • Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach is an excellent resource for clinicians who care for individuals affected by alcohol use disorders in diverse settings. Although alcohol abuse alone does not cause acute lung injury, it renders the lung susceptible to dysfunction in response to the inflammatory stresses of sepsis, trauma, and other clinical conditions recognized to cause acute lung injury. In parallel, these same pathophysiological effects of alcohol abuse significantly increase the risk of a wide range of serious lung infections. Many clinicians involved in the primary treatment of alcohol use disorders, such as addiction psychiatrists, will find this text of interest as it will expand their understanding of the health consequences of alcohol use disorders. In parallel, clinicians who specialize in pulmonary and/or critical care medicine will have a unique resource that provides a comprehensive review of the pathophysiology of alcohol-related lung disorders and insights into evolving therapeutic options in these vulnerable individuals. Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach fills a gap in the literature and presents the evolving clinical research that may soon lead to novel therapies that can improve lung health in individuals with alcohol use disorders and co-existing conditions such as HIV infection.
  • Part 1 : The basis of addictive disorders -- Neurobiology of addiction / George F. Koob -- Genetics of addiction / Joel Gelernter, Henry R. Kranzler -- Epidemiology of addiction / Judith S. Brook, Kerstin Pahl, Elizabeth Rubenstone -- Cross-cultural aspects of addiction / Nady el-Guebaly --Part 2 : The nature of treatment -- Assessment of the patient / Shelly F. Greenfield, Grace Hennessy -- Patient placement criteria / David Mee-Lee, David R. Gastfriend -- Evolution in addiction treatment concepts and methods / A. Thomas McLellan --Part 3 : Specific drugs of abuse -- Alcohol -- Neurobiology of alcohol / Clifford M. Knapp, Domenic A. Ciraulo, Henry R. Kranzler -- Clinical management of alcohol abuse and dependence / Hugh Myrick, Tara Wright -- Stimulants -- Neurobiology of stimulants / Margaret Haney -- Clinical management : cocaine / Thomas R. Kosten, Mehmet Sofuoglu, Tracie J. Gardner -- Clinical management : methamphetamine / Richard A. Rawson, Walter Ling -- Hallucinogens and club drugs -- Neurobiology of hallucinogens / Richard A. Glennon -- Hallucinogens and club drugs / Michael F. Weaver, Sidney H. Schnoll -- Other substances -- Nicotine and tobacco / Tony P. George, Andrea H. Weinberger -- Benzodiazepines and other sedatives and hypnotics / Adam Bisaga -- Treatment of anabolic-androgenic steroid-related disorders / Harrison G. Pope, Jr., Kirk J. Brower -- Opioids -- Neurobiology of opiates and opioids / Mary Jeanne Kreek -- Detoxification of opioids / Soteri Polydorou, Herbert D. Kleber -- Opioid maintenance treatment / Richard S. Schottenfeld -- Buprenorphine maintenance / Eric C. Strain, Michelle R. Lofwall -- Antagonists of opioids / Charles O'Brien, Kyle M. Kampman --Part 4 : Treatment modalities -- Psychodynamics / Hallie A. Lightdale, Avram H. Mack, Richard J. Frances -- Cognitive-behavioral therapies / Kathleen M. Carroll -- Motivational enhancement / Carlo C. DiClemente, Miranda Garay, Leigh Gemmell -- Twelve-step facilitation / Richard K. Ries, Marc Galanter, J. Scott Tonigan -- Contingency management / Stephen T. Higgins, Kenneth Silverman -- Network therapy / Marc Galanter -- Group therapy / David W. Brook -- Family therapy / Timothy J. O'Farrell, William Fals-Stewart --Part 5 : Rehabilitation settings -- Inpatient treatment / Roger D. Weiss, Jennifer Sharpe Potter, Rocco A. Iannucci -- Therapeutic communities / George De Leon -- Community-based treatment / Jonathan I. Ritvo, Harvey L. Causey III -- Alcoholics anonymous and other 12-step programs -- Psychological mechanisms in alcoholics anonymous / J. Scott Tonigan, Gerard J. Connors -- The history of alcoholics anonymous and the experiences of patients / Edgar P. Nace -- Outcome research on 12-step and other self-help programs / Rudolf H. Moos, Christine Timko --Part 6 : Special populations -- Adolescent substance abuse / Yifrah Kaminer -- The mentally ill substance abuser / Stephen Ross -- Women and addiction / Kathleen T. Brady, Sudie E. Back -- Perinatal substance abuse / Loretta P. Finnegan, Stephen R. Kandall -- HIV/AIDS and hepatitis C / Steven L. Batki, Kalpana I. Nathan -- Prescription drug abuse / Wilson M. Compton, Richard Denisco -- Substance use disorders among physicians / J. Wesley Boyd, John R. Knight -- Gay men and lesbians / Robert Paul Cabaj -- Minorities / Joseph Westermeyer, Daniel Dickerson --Part 7 : Special topics -- Testing to identify recent drug use / Robert L. DuPont, Carl M. Selavka -- Medical education / Erik W. Gunderson, Frances R. Levin, Petros Levounis -- Prevention of substance abuse / Richard R. Clayton, Melissa J.H. Segress, Crystal A. Caudill -- Forensic addiction psychiatry / Avram H. Mack, Monica Barros.
  • Animal models of drug addiction 2011, Springer Protocols
    Intracranial self-stimulation /Styliani Vlachou and Athina Markou --Stimulant self-administration /Leigh V. Panlilio --Opiate self-administration /Francesco Leri --Nicotine self-administration / Robert E. Sorge and Paul B.S. Clarke --Alcohol self-administration /Friedbert Weiss --Place conditioning /Christopher L. Cunningham, Peter A. Groblewski, and Charlene M. Voorhees --Sensitization /Jessica A. Loweth and Paul Vezina --Animal models of eating disorders /Stephanie D. Hancock and Mary C. Olmstead --Acquisition of drug self-administration /Marilyn E. Carroll and Richard A. Meisch --Escalation of drug use /Serge H. Ahmed --Environmental modulation of drug taking /Aldo Badiani ... [et al.] --Craving /Jeffrey W. Grimm --Habit formation and compulsion /David Belin ... [et al.] --Impulsivity /Andrea Bari, Trevor W. Robbins, and Jeffrey W. Dalley --Binge drug taking / Herbert E. Covington, III and Klaus A. Miczek --Withdrawal /Alasdair M. Barr, Heidi N. Boyda, and Ric M. Procyshyn --Relapse /Suzanne Erb and Franca Placenza.
  • Theoretical issues -- Epidemiological perspectives on co-occurring anxiety disorder and substance use disorder -- The neurobiology of anxiety: potential for co-morbidity of anxiety and substance use disorders -- Research findings -- Posttraumatic stress disorder and substance use disorder: neuroimaging, neuroendocrine, and psychophysiological findings -- Co-morbidity of social phobia and alcohol use disorders: a review of psychopathology research findings -- Panic spectrum disorders and substance use -- Treatment strategies -- Treatment of co-morbid obsessive-compulsive disorder and substance use disorders -- Treatment for co-morbid posttraumatic stress disorder and substance use disorders -- Treatment of co-occurring alcoholism and social anxiety disorder -- Treating co-morbid panic disorder and substance use disorder -- Cognitive- behavioral treatment of co-morbid panic psychopathology and tobacco use and dependence -- Personality-based approaches to treatment of co-morbid anxiety and substance use disorder -- Medical management of co-morbid anxiety and substance use disorder -- Integration and conclusions -- Anxiety disorder and substance use disorder co-morbidity: common themes and future directions.
  • ASSIST 2005, NCI
  • Part I. Mechanistic Aspects Underlying Alcoholism -- Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit Disorder / George F. Koob -- Synaptic Effects Induced by Alcohol / David M. Lovinger and Marisa Roberto -- Signaling Pathways Mediating Alcohol Effects / Dorit Ron and Robert O. Messing -- Neurocircuitry Involved in the Development of Alcohol Addiction: The Dopamine System and its Access Points / Bo Söderpalm and Mia Ericson -- What is in that Drink: The Biological Actions of Ethanol, Acetaldehyde, and Salsolinol / Gerald A. Deehan Jr., Mark S. Brodie and Zachary A. Rodd -- Part II. Genetics -- Modeling the Diagnostic Criteria for Alcohol Dependence with Genetic Animal Models / John C. Crabbe, Kenneth S. Kendler and Robert J. Hitzemann -- Non-Human Primate Models of Alcohol-Related Phenotypes: The Influence of Genetic and Environmental Factors / Christina S. Barr -- Genetically Selected Alcohol Preferring Rats to Model Human -- Alcoholism / Roberto Ciccocioppo -- Advanced Transgenic Approaches to Understand Alcohol-Related Phenotypes in Animals / Ainhoa Bilbao -- Part III. Clinical Phenotypes and Preclinical Models Thereof Modeling Alcohol Self-Administration in the Human Laboratory / Ulrich S. Zimmermann, Sean O'Connor and Vijay A. Ramchandani -- Animal Models of Excessive Alcohol Consumption in Rodents / Howard C. Becker -- Modeling Relapse Situations in the Human Laboratory / Rajita Sinha -- Modeling Relapse in Animals / Rémi Martin-Fardon and Friedbert Weiss -- Invertebrate Models of Alcoholism / Henrike Scholz and Julie A. Mustard -- Part IV. Novel Insights from Brain Imaging The Dopamine System in Mediating Alcohol Effects in Humans / K. Charlet, A. Beck and A. Heinz -- Stimulant and Sedative Effects of Alcohol / Reuben A. Hendler, Vijay A. Ramchandani, Jodi Gilman and Daniel W. Hommer -- Chronic Alcohol Consumption, Abstinence and Relapse: Brain Proton Magnetic Resonance Spectroscopy Studies in Animals and Humans / Dieter J. Meyerhoff, Timothy C. Durazzo and Gabriele Ende -- Part V. Translational Aspects and Medication Development -- Translational Approaches to Medication Development / Selena Bartlett and Markus Heilig -- New Pharmacological Treatment Strategies for Relapse Prevention / Rainer Spanagel and Valentina Vengeliene -- The Challenge of Studying Parallel Behaviors in Humans and Animal Models / David N. Stephens, Hans S. Crombag and Theodora Duka -- A Translational Approach to Novel Medication Development for Protracted Abstinence / Barbara J. Mason and Amanda E. Higley -- New Approaches to Addiction Treatment Based on Learning and Memory / Falk Kiefer and Christina Dinter -- Adolescent Substance Misuse: Neurobiology and Evidence-Based Interventions / Nicola C. Newton, Maeve O'Leary-Barrett and Patricia J. Conrod -- Deep Brain Stimulation as a Therapy for Alcohol Addiction / Thomas F. Münte, Hans-Jochen Heinze and Veerle Visser-Vandewalle.
  • Ch. 1. Hydrocarbons -- ch. 2. Alcohols and phytosterols -- ch. 3. Aldehydes and ketones -- ch. 4. Carboxylic acids -- ch. 5. Esters -- ch. 6. Lactones -- ch. 7. Anhydrides -- ch. 8. Carbohydrates and their derivatives -- ch. 9. Phenols and quinones -- ch. 10. Ethers -- ch. 11. Nitriles -- ch. 12. Acyclic amines -- ch. 13. Amides -- ch. 14. Imides -- ch. 15. N-nitrosamines -- ch. 16. Nitroalkanes, nitroarenes, and nitrophenols -- ch. 17. Nitrogen heterocyclic components -- ch. 18. Miscellaneous components -- ch. 19. Fixed and variable gases -- ch. 20. Metallic and nonmetallic elements, isotopes, ions, and salts -- ch. 21. Pesticides and growth regulators -- ch. 22. Genes, nucleotides, and enzymes -- ch. 23. Hoffmann analytes -- ch. 24. Tobacco and/or tobacco smoke components used as tobacco ingredients -- ch. 25. Pyrolysis -- ch. 26. Carcinogens, tumorigens, and mutagens vs. anticarcinogens, inhibitors, and antimutagens -- ch. 27. Free radicals -- ch. 28. Summary.
  • Patients with chronic pain understandably seek relief from their distress and discomfort, but many medications that alleviate pain are potentially addictive, and most chronic pain conditions only have a temporary response to opiate analgesic drugs. This volume reviews the fundamental topics that underlie the complex relationships of this controversial domain. The authors review behavioral models and practical methods for understanding and treating chronic pain and addiction including methods to formulate patients with complex comorbidity and screen patients with chronic pain for addictive liability. Finally, the authors describe the current findings from clinical and basic science that illuminate the role of opiates, cannabinoids and ketamine in the treatment of chronic pain. Up to date and comprehensive, this book is relevant to all professionals engaged in the care of patients with chronic pain or addiction and all others interested in these contemporary issues, particularly non-clinicians seeking clarity in the controversy over the best approach to patients with chronic pain.
  • The volume presents current material on the key neurobiological and genetic elements in an individual's susceptibility to drug dependence as well as the processes by which some individuals proceed from casual drug use to drug dependence. Chapters describe and explain the neurobiological mechanisms of drug use and drug addiction. The development and use of animal models to study neurochemical, molecular and cellular brain mechanisms are described and illustrated. Other chapters discuss the effects of drug use on memory, decision-making, and the developing brain (especially in adolescents).
  • Volume 3, Intervention for Addictions, provides chapters on psychosocial treatments, pharmacological treatments, provision of health care to addicted individuals, prevention, and public policy issues. Basically, this volume contains the practical application of the information in Volumes 1 and 2. Overall, this volume provides a detailed picture of the myriad of science-based interventions available for the treatment of addiction. With the expanding growth of neurobiological research newer and more effective pharmacological treatments should be available on the near horizon.
  • Part I. General aspects of alcohol toxicity, consumption, and disease -- Part II. Damage/disease: -- General aspects of pathology -- Organ damage -- Cells, pathways, interactions, processes -- Part III. Selective methods used in alcohol research -- Index.
  • Pt. 1. Pharmacological-based models of addiction -- pt. 2. Neurocomputational models of addiction -- pt. 3. Economic-based models of addiction.
  • Criminalistics: introduction to controlled substances / Joseph P. Bono -- Pathology of drug abuse / edited by Charles V. Wetli -- Pharmacokinetics: drug absorption, distribution, and elimination / Amanda J. Jenkins -- Pharmacodynamics / edited by Stephen J. Heishman -- Alcohol / edited by Alan Wayne Jones -- Neurochemistry of drug abuse / edited by Julie K. Staley and Kelly P. Cosgrove -- Addiction medicine / edited by Kim Wolff -- Medical complications of drug abuse / edited by Neal L. Benowitz -- Sports / edited by Marc D. Bollmann and Martial Saugy -- Workplace testing / edited by Yale H. Caplan and Marilyn A. Huestis -- Point of collection drug testing / edited by Dennis J. Crouch -- Post-mortem toxicology / edited by Henrik Druid -- Toxicogenetics / edited by Steven B. Karch -- Drug law -- Appendices.
  • Drug addiction 2008, Springer
  • Depressants -- Alcoholism: an introduction -- Alcoholism: acute treatment -- Stimulants: amphetamines and cocaine -- Opioids and other analgesics -- Cannabinols -- Hallucinogens and related drugs -- Glues, inhalants and aeorsols -- Over-the-counter (OTC) drugs and some prescription drugs -- Xanthines (caffeine) and nicotine -- Multidrug abuse and dependence -- Emergency problems: a quick overview -- Rehabilitation.
  • Drugs of abuse 2005, Springer
  • Dual diagnosis 2005, Karger
    Etiological theories on the relationship of mental disorders and substance use disorders / Moggi, F. -- The genetic basis of substance use and abuse / Jacobson, K.C. -- Paths of genetic and environmental influence: the routes connecting personality disorders with substance use disorders / Cadoret, R.J. ... [et al.] -- Historical and conceptual issues / Jacobs, W.S., Cahill, K.S., Gold, M.S. -- Comorbidity in alcohol use disorders: focus on mood, anxiety and personality / Hintz, T., Mann, K. -- Having attention-deficit/hyperactivity disorder and substance use disorder: a review of the literature / Eich, D., Figner, B. -- Diagnostic issues in dual diagnosis patients / Petitjean, S. -- Neurocognitive impairment: an underdiagnosed comorbid entity in the treatment of substance use disorders / Dorsteler-MacFarland, K.M., Cereghetti, K.H., Wiesbeck, G.A. -- Modified therapeutic communities for co-occurring substance abuse and psychiatric disorders / Leon, G.D.
  • Eating disorders, addictions, and substance use disorders are each challenging in their own right, but they also commonly co-occur, causing major challenges for clinicians. Emerging research suggests that there are common substrates at the neuroanatomical, neurochemical, and psychological levels. While randomized controlled trials have revealed a number of effective psychotherapeutic and psychopharmacologic treatments for the individual conditions, little is known about integrative interventions for these comorbidities. This book presents cutting-edge research on the overlap of these complex disorders and reviews integrative assessment strategies and treatment approaches, including enhanced cognitive behavioral therapy, dialectical behavior therapy, abstinence approaches, motivational enhancement, mindfulness meditation, and pharmacotherapy. The issue of whether eating-disordered behaviors such as dieting, binge eating, and excessive exercise are merely other forms of addictive behavior is examined. The authors argue both for and against the concept of food addiction in research, clinical treatment, and public policy.
  • Drug use and abuse continues to thrive in contemporary society worldwide and the instance and damage caused by addiction increases along with availability. The Effects of Drug Abuse on the Human Nervous System presents objective, state-of-the-art information on the impact of drug abuse on the human nervous system, with each chapter offering a specific focus on nicotine, alcohol, marijuana, cocaine, methamphetamine, MDMA, sedative-hypnotics, and designer drugs. Other chapters provide a context for drug use, with overviews of use and consequences, epidemiology and risk factors, genetic.
  • Introduction to the guidelines. Purpose, target and scope -- Background -- A dual obligation, a quadruple imperative -- Indispensability of controlled medicines in contemporary medical practices -- Safety of controlled medicines -- Current availability -- Impediments to availability, accessibility and affordability -- Why and how to work with this document? -- Guidelines for ensuring balance in national policies on controlled substances. Content of drug control legislation and policy -- Authorities and their role in the system -- Policy planning for availability and accessibility -- Healthcare professionals -- Estimates and statistics -- Procurement -- Other -- Country assessment checklist.
  • Defining and measuring drug abusing behaviors / Zili Sloboda -- Drug abuse heterogeneity and the search for subtypes / Meyer D. Glantz, Devin P. Conway and James D. Colliver -- Studying the natural history of drug use / Yih-Ing Hser ... [et al.] -- Health, social and psychological consequences of drug use and abuse / Michael D. Newcomb and Thomas Locke -- Use of archival data / Zili Sloboda, Rebecca McKetin and Nicholas J. Kozel -- Sampling issues in drug epidemiology / Colin Taylor and Paul Griffiths -- Collecting drug use data from different populations / Edward M. Adlaf -- Indirect methods to estimate prevalence / Matthew Hickman and Colin Taylor -- Qualitative methods in the drug abuse field / Claire E. Sterk and Kirk W. Elifson -- Ethical considerations for drug abuse epidemiologic research / Craig L. Fry and Wayne Hall --A common language for a common problems: the developing role of drug epidemiology in a global context / Paul Griffiths and Rebecca McKetin -- Longitudinal studies of drug use and abuse / Thomas A. Wills, Carmella Walker and Jody A. Resko -- Drug abuse and the spread of infection: HIV and AIDS as an example / Don C. Des Jarlais, Holly Hagan and Samuel R. Friedman -- Implications of epidemiologic information for effective drug abuse prevention strategies / Zili Sloboda -- The role of treatment data in studying the epidemiology of substance use and abuse / Robert L. Hubbard.
  • Measuring acute alcohol impairment / Christopher S. Martin -- Update on clinical and forensic analysis of alcohol / Alan Wayne Jones and Derrick J. Pounder -- Post-mortem alcohol: aspects of interpretation / Derrick J. Pounder and Alan Wayne Jones -- Recent advances in biochemical tests for acute and chronic alcohol consumption / Anders Helander and Alan Wayne Jones -- Alcohol determination in point of collection testing / J. Robert Zettl.
  • Fragmented intimacy 2008, Springer
    PART 1: THEORY -- Addiction in Perspective -- Dangerous Consumptions -- Overview of this Book -- Companion Relationships -- A Social World -- Worlds, Paradigms and Assumptions -- The Particle Paradigm -- The Social Paradigm -- Switching to a Social World -- Addiction and Connecting -- Connecting to the World -- Patterns of Fragmentation -- Responding to Addiction -- The Prospect of Change -- Setting Out and Setting Back -- Making it Stick -- PART 2: PROCESSES -- Becoming Intimate -- Living in Relationships -- Intimacy and the "Four Cs" -- Special Considerations -- Quality Intimacy? -- Intimacies in Addictive Contexts -- Intimacy within Addictive Relationships -- Intimacies for Others -- Systems of Intimate Connections -- Intimacy and Power -- Controlling Tactics -- The Myth of Disinhibition -- Violence as a Social Event -- Managed Intimacy -- PART 3: FAMILIES & COMMUNITIES -- Fragmented Lives -- Fragmenting Environments -- How Intimates Respond -- Broader Social Dynamics -- Collective Opportunities -- Empowerment and Connectedness -- Reconnecting Intimates -- Responsibility for Change -- Change Processes -- Guidelines for Effective Collective Action -- Reintegration -- What is Reintegration? -- Six Phases of Reintegration -- Reforming Intimacies -- Enabling Closeness and Compassion -- Domains of Connectedness -- PART 4: APPLICATIONS -- Family Resources -- Social Resources from Inner Power -- Social Resources Offered by Services -- Mobilizing Communities -- Volunteer Networks -- Croatian/Italian Community Clubs -- An Indigenous Approach -- Applications to Practice -- Barriers to Social Inclusive Practice -- Social Engagement -- Social Assessment -- Facilitative Meetings -- Looking Ahead -- Where It Fits -- Future Opportunities
  • "This publication contributes to the scientific understanding of gender, women, and tobacco in the context of efforts to control the global tobacco epidemic. Topics covered include determinants of starting to use tobacco; exposure to second-hand smoke; the impact that tobacco use has on health; addiction and cessation; treatment programs; and gender and human rights policy. The publication also addresses national economic policy with regard to tobacco control, international treaties, and strategies for tobacco-free mobilization at the regional and international levels. Special attention is paid to an analysis of policies that affect girls and women throughout the life course. Men's responsibility to protect women against second-hand smoke is also highlighted"--Publisher's description.
  • "This publication presents a comprehensive perspective on the worldwide, regional and country consumption of alcohol, patterns of drinking, health consequences and policy responses in member states. It represents a continuing effort by WHO to support member states with global information in their efforts to reduce the harmful use of alcohol and its health and social consequences"--Publisher's description.
  • The Global status report on alcohol and health 2014 presents a comprehensive perspective on the global, regional and country consumption of alcohol, patterns of drinking, health consequences and policy responses in Member States. It represents a continuing effort by the World Health Organization (WHO) to support Member States in collecting information in order to assist them in their efforts to reduce the harmful use of alcohol, and its health and social consequences. The report was launched in Geneva on Monday 12 May 2014 during the second meeting of the global network of WHO national counterparts for implementation of the global strategy to reduce the harmful use of alcohol.--Publisher's description.
  • These guidelines review the use of medicines such as methadone, buprenorphine, naltrexone and clonidine in combination with psychosocial support in the treatment of people dependent on heroin or other opioids. Based on systematic reviews of the literature and using the GRADE approach to determining evidence quality, the guidelines contain specific recommendations on the range of issues faced in organizing treatment systems, managing treatment programs and in treating people dependent on opioids.--back cover
  • I: HISTORICAL OVERVIEW: The emerging science of drug abuse prevention / William J. Bukoski -- II: SOCIAL CONTEXTS OF PREVENTION: Effective mass media strategies for drug abuse prevention campaigns / Philip Palmgreen and Lewis Donohew -- Drug abuse prevention curricula in schools / Gilbert J. Botvin and Kenneth W. Griffin -- Dissemination of research-based family intervention for the prevention of substance abuse / Karol L. Kumpfer and Steve Adler -- Peers and the prevention of adolescent drug use -- / E. R. Oetting and R. S. Lynch -- Mobilizing communities to reduce risk for drug abuse: a comparison of two strategies / Michael W. Arthur, Charles D. Ayers, Kelly A. Graham, and J. David Hawkins -- Community-focused drug abuse prevention / Barry M. Kibel and Harold D.Holder -- Drug abuse prevention in the workplace / Royer F. Cook -- Prevention approaches to methadone treatment settings: children of drug abuse treatment clients / Richard F. Catalano, Kevin P. Haggerty, and Randy R. Gainey -- III: PREVENTION AS SOCIAL CONTROL: Drug tests in prevention research / Robert L. DuPont and Keith E. Saylor -- Anti-drug-abuse policies on prevention strategies / Mary Ann Pentz -- IV: THEORETICAL AND EMPIRICAL FOUNDATIONS OF PREVENTION: Forging a relationship between drug abuse epidemiology and drug abuse prevention / Zili Sloboda -- Risk and protective factors of adolescent drug use: implications for prevention programs / Judith S. Brook. David W. Brook, Linda Richter, and Martin Whiteman -- Bridging the gap between substance use prevention theory and practice / Brian R. Flay and John Petraitis -- Preventive intervention targeting precursors / John E. Lochman -- Designing prevention programs: the developmental perspective / Marvin W. Berkowitz and Audrey L. Begun --V: SPECIAL POPULATIONS: Gender issues in substance abuse prevention / Louise Ann Rohrbach and Joel Milam -- Preventing substance use among Latino youth / Charles R. Martinez, Jr., J. Mark Eddy, and David S. DeGarmo -- African-American substance use epidemiology and prevention issues / William L. Turner and Michael J. Hench -- The effectiveness of alcohol and drug abuse prevention among American-Indian youth / Fred Beauvais and Joseph E. Trimble -- Drug abuse prevention research for Asian and Pacific Islander Americans / W. William Chen -- VI: INTERACTIONS BETWEEN BIOLOGY AND SOCIAL CONTEXT: RISKS FOR MULTIPLE BEHAVIORAL AND MENTAL DISORDERS: Basic science and drug abuse prevention: neuroscience, learning, and personality perspectives / Michael T. Bardo, Thomas Kelly, Donald R. Lynam, and Richard Milich -- Cross-national comparisons of co-morbidities between substance use disorders and mental disorders / Ronald C. Kessler, Sergio Aguilar-Gaxiola, Laura Andrade, Rob Bijl ... [et al.] -- Drug abuse research for high-risk youth / Leona L. Eggert and Brooke P. Randell -- Research designs for family studies / Michael Vanyukov, Howard Moss, and Ralph E. Tarter -- VII: RESEARCH DESIGN, MEASUREMENT, AND DATA ANALYTIC ISSUES: Design principles and their application in preventive field trials / C. Hendricks Brown -- Major data analysis issues in drug abuse prevention research / David P. MacKinnon and James H. Dwyer -- Metholological considerations to prevention research / Linda M. Collins and Brian P. Flaherty -- Prevention program implementation / Steven Schinke and Kristin Cole -- Family management practices: research design and measurement issues / Thomas J. Dishion, Bert Burraston, and Fuzhong Li -- Power analysis models and methods: a latent variable framework for power estimation and analysis / Terry E. Duncan, Susan C. Duncan, and Puzhong Li -- VIII: DRUG ABUSE PREVENTION: A LOOK TO THE FUTURE: Application of computer technology to drug abuse prevention / Kris Bosworth -- Putting science into practice / Gale Held.
  • Introduction to therapeutic drug monitoring. -- Monitoring free drug concentration. -- Analytical techniques for measuring concentrations of therapeutic drugs in biological fluids. -- The pre-analytical phase of drug testing: from specimen collection to analysis. -- Effect of hemolysis, high bilirubin, lipemia, paraproteins, and system factors on therapeutic drug monitoring. -- Digoxin: so many interferences and how to eliminate them. -- Interferences with measurement of anticonvulsants. -- Pitfalls in measuring antidepressant drugs. -- Immunosuppressive drugs: pharmacokinetics, preanalytic variables, and analytical considerations. -- Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. -- Pharmacogenetics and personalized medicine: issues and methodology. -- Interference of heterophilic and other antibodies in measurement of therapeutic drugs by immunoassays. -- Drug-herb and drug-food interactions: impact on therapeutic drug monitoring. -- Toxic element testing with clinical specimens. -- Alcohol testing. -- Introduction to drugs of abuse testing. -- Urinary adulterants and drugs of abuse testing. -- Hair, oral fluid, sweat, and meconium testing for drugs of abuse: advantages and pitfalls. -- Abused and designer drugs and how they escape detection. -- Interpretation of amphetamines screening and confirmation testing. -- Clinical false-positive drug test results. -- Providing expert witness for alcohol and positive drugs of abuse test results.
  • Cocaine -- Natural stimulants -- Synthetic stimulants -- Hallucinogens -- Opiates and opioids -- Dissociative anesthetics -- Anabolic steroids -- Solvents -- Marijuana -- Appendix 1: Conversion formulas -- Appendix 2: Blood alcohol concentrations -- Appendix 3: Volume of distribution calculations -- Appendix 4: Normal heart weights.
  • "A comprehensive, authoritative text on all aspects of substance abuse and addiction medicine. Scientific topics such as the biology of various addictions and all dimensions of clinical treatment and management are addressed by a wide range of leading contributors. Behavioral addictions are addressed also, so the text is not solely devoted to specific substances and their misuse"--Provided by publisher.
  • Methamphetamine use 2003, CRCnetBASE
  • The mhGAP-IG has been developed through an intensive process of evidence review. A WHO Guideline Development Group of international experts conducted systematic reviews to develop evidence-based recommendations. The recommendations were then converted into clearly presented stepwise interventions and then circulated among a wider range of reviewers across the world to include all the diverse contributions. The mhGAP-IG is based on the mhGAP Guidelines on interventions for mental, neurological and substance use disorders (http:// www.who.int/mental_health/mhgap/evidence/en/). Both documents will be reviewed and updated in 5 years. Any revision and update before that will be made to the online version of the document.--(excerpt, p. 1).
  • Humans are biologically programmed to seek out pleasurable experiences. These experiences are processed in the mesolimbic system, also referred to as the "reward center" of the brain, where a number of chemical messengers work in concert to provide a net release of dopamine in the Nucleus Accumbens. In some genetically predisposed individuals, addiction occurs when the mechanisms of the mesolimbic system are disrupted by the use of various drugs of abuse. Since Alcoholics Anonymous was founded in 1935, it's 12 step program of spiritual and character development has helped countless alcoholics and drug addicts curb their self-destructive behaviors. However, the program was developed at a time when comparatively little was known about the function of the brain and it has never been studied scientifically. This is the first book to take a systematic look at the molecular neurobiology associated with each of the 12 steps and to review the significant body of addiction research literature that is pertinent to the program.
  • This title draws upon research on the drug widely believed to form the basis of tobacco use and dependence, nicotine. When discussing drug addiction and dependence, an increasing number of scientists are using the concepts of motivation and related constructs and their applications in modifying behavior.
  • Rapid advances in understanding neural-immune interactions have far reaching impact on research in many areas of neuroscience. It is becoming increasingly clear that neuroimmune factors modulate a wide range of brain functions and play an important role in development, normal brain function, and CNS dysfunctions, including neurodegenerative diseases, neuropsychiatric disorders and addiction. "Neural.Immune Interaction in Brain Function and Alcohol Related Disorders" integrates emerging knowledge on neural-immune interactions with related key discoveries in alcohol research to provide a comprehensive overview of neuroimmune system in brain function and behavior associated with alcohol use disorders. Readers will benefit from cutting edge insights provided by outstanding, active researchers in the fields of neuroimmune research and alcohol use disorders.
  • Neurobiology of addiction 2006, ScienceDirect
    What is addiction? -- Animal models of drug addiction -- Psychostimulants -- Opioids -- Alcohol -- Nicotine -- Cannabinoids -- Imaging -- Neurobiological theories of addiction -- Drug addiction : transition from neuroadaptation to pathophysiology.
  • The dopamine transporter and addiction / William M. Meil and John W. Boja -- Neurochemistry of nicotine dependence / Darlene H. Brunzell -- Neurochemical substrates of habitual tobacco smoking / Irina Esterlis, Suchitra Krishnan-Sarin, and Julie K. Staley -- Neurochemical and neurobehavioral consequences of methamphetamine abuse / Colin N. Haile -- Neurochemical adaptations and cocaine dependence / Kelly P. Cosgrove and Julie K. Staley -- Neuropsychiatric consequences of chronic cocaine abuse / Deborah C. Mash -- Neurobiology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") / Michael H. Baumann and Richard B. Rothman.
  • Novel psychoactive substances 2013, ScienceDirect
  • The criminalistics of controlled substances / Joseph P. Bono -- Overview of pathology of drug abuse : scene of death and the autopsy / Charles V. Wetli -- Heart disease / Renu Virmani, Allen P. Burke, Andrew Farb -- Vascular effects of substance abuse / Frank D. Kolodgie, Allen P. Burke, Jagat Narula, Florabel G. Mullick, Renu Virmani -- Myocardial alterations in drug abusers / Steven B. Karch -- Valvular heart disease / Michael D. Bell -- Lung disease / Michael D. Bell -- Disorders of the central nervous system / Michael D. Bell -- Toxicogenetics in drug abuse : pharmacogenomics for toxicology / Robert M. White, Steven H.Y. Wong -- Toxicogenetics in drug abuse : heritable channelopathies and myopathies / Kathryn A. Glatter, Jonica Calkins, Sanjay J. Ayirookuzhi.
  • Perioperative addiction 2012, Springer
  • Introduction to postmortem toxicology / W. Lee Hearn and H. Chip Walls -- Specimen selection, collection, preservation, and security / Bradford R. Hepler and Daniel S. Isenschmid -- Common methods in postmortem toxicology / W. Lee Hearn and H. Chip Walls -- Strategies for postmortem toxicology investigation / edited and revised by Henrik Druid -- Quality assurance in postmortem toxicology / Wilmo Andollo -- Interpretation of postmortem drug levels / Graham R. Jones.
  • The phenomenon of self-change: overview and key issues -- Self-change from alcohol and drug abuse: often-cited classics -- Natural recovery or recovery without treatment from alcohol and drug problems as seen from survey data -- Remission without formal help: new directions in studies using survey data -- Natural recovery from alcohol and drug problems: a methodological review of the literature from 1999 through 2005 -- Self-change in a broader context: beyond alcohol and drugs -- One way to leave your lover: the role of treatment in changing addictive behaviors -- Promoting self-change: taking the treatment to the community -- Hostile and favorable societal climates for self-change: some lessons for policymakers -- Natural recovery: a cross-cultural perspective -- Self-change toolbox: tools, tips, websites, and other informational resources for assessing and promoting self-change.
  • From nicotine dependence to genetic determinants of smoking -- State of the art of smoking habits in the world -- Smoking-related diseases epidemiology -- Smoking-related cancer epidemiology -- Classical determinants of smoking initiation -- Smoking prevention in the communities -- Smoking prevention through mass media campaigns -- How to tackle smoking at the population level -- Smoking among health professionals -- Basic principles of smoking cessation techniques -- Smoking cessation among different settings -- Media and smoking cessation -- Ethical aspects of tobacco smoking -- Economic issues related to tobacco smoking -- Appendix.
  • I. Etiological factors -- 1. Determinants of substance abuse and dependence -- II. Substances of abuse -- 2. Alcohol -- 3. Opiates -- 4. Cocaine -- 5. Marijuana -- 6. Amphetamines and other stimulants -- 7. Sedative-hypnotics -- 8. Hallucinogens -- 9. Phencyclidine (pcp) -- 10. Inhalants -- 11. Mdma/designer drugs -- 12. Nicotine -- 13. Caffeine -- 14. Anabolic-androgenic steroids -- III. Compulsive and addictive behaviors -- 15. Eating disorders -- 16. Pathologic gambling -- 17. Sexual addiction -- IV. Evaluation and diagnostic classification -- 18. Classification, diagnosis and diagnostic laboratory -- V. Treatments modalities -- 19. Detoxification -- 20. Methadone treatment -- 21. Buprenorphine for the treatment of opioid addiction -- 22. Alternative pharmacotherapies for opioid addiction -- 23. Acupuncture -- 24. Individual psychotherapy -- 25. Group therapy -- 26. Family/couples approaches to treatment engagement and therapy -- 27. Cognitive and behavioral therapy -- 28. Alcoholics anonymous -- 29. The therapeutic community -- 30. Network therapy -- 31. Faith-based approaches -- 32. Relapse prevention -- 33. Treatment in prisons and jails -- VI. Management of associated medical conditions -- 34. Maternal and neonatal effects of alcohol and drugs -- 35. Medical complications of drug use -- 36. HIV infections and AIDS -- 37. Acute and chronic pain -- 38. Substance use disorders in individuals with co-occurring psychiatric disorders -- VII. Life cycle -- 39. Substance abuse and the life cycle: children, adolescents and the elderly -- VIII. Women's issues -- 40. Alcohol and drugs among women -- IX. Special groups/settings -- 41. Disability and rehabilitation issues -- 42. The workplace and methadone advocacy -- 43. Physicians and other health professionals -- X. Models of prevention -- 44. The public health approach to the prevention of substance abuse -- XI. Training and education -- 45. Medical education and Clinical Personnel Training -- 46. Forensics.
  • The need for college recovery services / Richard P. Wiebe, H. Harrington Cleveland, and Kitty S. Harris -- Collegiate recovery communities : what they are and how they support recovery / Kitty S. Harris, Amanda Baker, and H. Harrington Cleveland -- Facilitating identity development in collegiate recovery : an Eriksonian perspective / Matthew Russell, H. Harrington Cleveland, and Richard P. Wiebe -- Characteristics of collegiate recovery community members / H. Harrington Cleveland, Amanda Baker, and Lukas R. Dean -- Maintaining abstinence in college : temptations and tactics / Richard P. Wiebe, H. Harrington Cleveland, and Lukas R. Dean -- Daily lives of young adult members of a collegiate recovery community / H. Harrington Cleveland and Allison Groenendyk -- How membership in the collegiate recovery community maximizes social support for abstinence and reduces risk of relapse / H. Harrington Cleveland, Richard P. Wiebe, and Jacquelyn D. Wiersma -- Building support for recovery into an academic curriculum : student reflections on the value of staff run seminars / Ann M. Casiraghi and Miriam Mulsow -- Establishing college-based recovery communities : opportunities and challenges encountered / Amanda Baker.
  • I.Foundations --Historical perspectives /David F. Musto --Epidemiology /Charles Winick and R.L. Norman --U.S. federal drug policy /Mathea Falco --II.Determinants of substance abuse and dependence --Genetic factors in the risk for substance use disorders /Show W. Lin and Robert M. Anthenelli --Brain-reward mechanisms /Eliot L. Gardner --Psychodynamics /Edward J. Khantzian, Lance Dodes, Nancy M. Brehm --Sociocultural issues /Bruce D. Johnson and Andrew Golub --III.Substances of abuse --Alcohol: neurobiology /Stephen L. Boehm II, C. Fernando Valenzuela, R. Adron Harris --Alcohol: clinical aspects /Bankole A. Johnson and Nassima Ait-Daoud --Opiates: neurobiology /Eric J. Simon --Opiates: clinical aspects /Clifford M. Knapp, Domenic A. Ciraulo, and Jerome Jaffe --Cocaine and crack: neurobiology /Martin Repetto and Mark S. Gold --Cocaine and crack: clinical aspects /Mark S. Gold and William S. Jacobs --The Neurobiology of marijuana /Sandra P. Welch --Marihuana: clinical aspects /Lester Grinspoon, James B. Bakalar, and Ethan Russo --Amphetamines and other stimulants /George R. King and Everett H. Ellinwood, Jr. --Sedative-hypnotics /Donald R. Wesson, David E. Smith, Walter Ling, and Richard B. Seymour --Hallucinogens /Robert N. Pechnick and J. Thomas Ungerleider --Phencyclidine (PCP) /Stephen R. Zukin, Zili Sloboda, and Daniel C. Javitt --Inhalants /Charles W. Sharp and Neil L. Rosenberg --Designer drugs /John P. Morgan --MDMA /Charles S. Grob and Russell E. Poland --Nicotine /Joy M. Schmitz and Katherine A. DeLaune --Caffeine /Laura M. Juliano and Roland R. Griffiths --Anabolic-androgenic steroids /Elyse R. Eisenberg and Gantt P. Galloway --Prescription opiate abuse /Walter Ling, Donald R. Wesson, and David E. Smith --IV.Related compulsive and addictive behaviors --Eating disorders /Mark S. Gold Jodi Star --Pathologic gambling /Sheila B. Blume and Hermano Tavares --Addiction and cults: synthesizing a model for treating ex-members /Ron Burks --Sexual addiction: nosology, diagnosis, etiology, and treatment /Aviel Goodman --Internet/computer addiction /Zebulon Taintor --Collecting, accumulation, and hoarding: acquisitions and their discontents /David A. Halperin and Jane Glick --V.Evaluation and early treatment --Diagnosis and classification: DSM-IV-TR and ICD-10 /John Cacciola and George E. Woody --Diagnostic laboratory: screening for drug abuse /Karl G. Verebey, Gerard Meenan, and Betty J. Buchan --VI.Treatment approaches --Detoxification /Grace Chang and Thomas R. Kosten --Alcoholics Anonymous /Edgar P. Nace --Alternative support groups /Arthur T. Horvath --The therapeutic community /William B. O'Brien and Fernando B. Perfas --Methadone maintenance /Joyce H. Lowinson, Ira Marion, Herman Joseph, John Langrod, Edwin A Salsitz, J. Thomas Payte, and Vincent P. Dole --Buprenorphine for the treatment of opioid addiction /Paul J. Fudala and Charles P. O'Brien --Alternative pharmacotherapies for opioid addiction /Paul J. Fudala, Robert A. Greenstein, and Charles P. O'Brien --Individual psychotherapy /Bruce J. Rounsaville, Kathleen M. Carroll, and Sudie Back --Group therapy with outpatients /Arnold M. Washton --Family/couples approaches to treatment engagement and therapy /M. Duncan Stanton and Anthony W. Heath --The role of coercion in drug treatment /Sally L. Satel and David J. Farabee --Treatment in prisons and jails /Roger H. Peters, Charles O. Matthews, and Joel A. Dvoskin --Cognitive and behavioral therapies /Lisa M. Najavits, Bruce S. Liese, and Melanie S. Harned --Network therapy /Marc Galanter --Acupuncture /Ji-Sheng Han, Alan I. Trachtenberg, and Joyce H. Lowinson --Faith-based approaches /John G. Langrod, John Muffler, James Abel, James T. Richardson, Eugenia Curet, Herman Joseph, and Pedro Ruiz --Relapse prevention /Dennis C. Daley and G. Alan Marlatt --Evaluation and outcome of treatment /Robert L. Hubbard --VII.Management of associated medical conditions --Maternal and neonatal effects of alcohol and drugs /Loretta P. Finnegan and Stephen R. Kandall --Medical complications of drug use /Marc N. Gourevitch and Julia H. Arnsten --Acute and chronic pain /Russell K. Portenoy, Richard Payne, and Steven D. Passik --Substance use disorders in individuals with co-occurring psychiatric disorders /Sylvia J. Dennison --VIII.HIV Infection and AIDS --Epidemiology and emerging public health perspectives /Don C. Des Jarlais, Holly Hagan, and Samuel R. Friedman --HIV-related medical complications and treatment /Chinazo O. Cunningham and Peter A. Selwyn --Neuropsychiatric aspects of HIV- infection /Francisco Fernandez, Jorge Maldonado, and Pedro Ruiz --Psychosocial issues of HIV/AIDS among drug users in treatment /James L. Sorensen, Nancy A. Haug, and Steven L. Batki --IX.Life cycle --Children of substance-abusing parents /Patti Juliana and Carolyn Goodman --Adolescents /Andres J. Pumariega, Mark D. Kilgus, and Leonardo Rodriguez --The elderly /Steven R. Gambert and Charles R. Albrecht III --X.Women's issues --Alcohol and women /Sheila B. Blume and Monica L. Zilberman --Drugs and women /Monica L. Zilberman and Sheila B. Blume --Women's research and policy issues /Marsha Rosenbaum and Sheigla Murphy --XI.Ethnic populations --African Americans: epidemiology, prevention, and treatment issues /Charles Madray, Lawrence S. Brown, Jr., and Beny J. Primm --Hispanic Americans /Pedro Ruiz and John G. Langrod --Asian Americans and Pacific Islanders /John W. Tsuang --Alcohol use among American Indians and Alaskan Natives /Edward F. Foulks --XII.Other populations --Gays, lesbians, and bisexuals /Robert Paul Cabaj --The homeless /Herman Joseph and John Langrod --Disability and rehabilitation issues /Allen W. Heinemann and Purva H. Rawal --Physicians and other health professionals /G. Douglas Talbott and Philip O. Wilson --New immigrants and refugees /Joseph Westermeyer --XIII.Models of prevention --School-based programs /Gilbert J. Botvin and Kenneth W. Griffin --Harm reduction: pragmatic drug policies for public health and safety /Ernest Drucker, Ethann Nadelman, Robert G. Newman, Alex Wodak, Jennifer McNeely, Kasia Malinowska-Semprucht, David Marsh, Martin Schechter, Bruna Brands, and Eugene Oscapella --Church, family, and community in the prevention and treatment of addiction among African Americans /Ronald Hopson and William B. Lawson --The public health approach to the prevention of substance abuse /Steven Jonas --XIV.Training and education --Medical education in substance abuse: the acquisition of knowledge, attitudes, and skills /John N. Chappel --Education and training of clinical personnel /David A. Deitch, Igor Koutsenok, and Karin Marsolais --Forensics /Milton Earl Burglass and Stuart Gitlow --The role of neuropsychological assessment in forensic addiction /Ari D. Kalechstein, Wilfred G. van Gorp, and Garrett J. Zelen --XV.Policy issues --A new era for methadone advocacy /Joycelyn Woods, Walter Ginter, and Tony Scro --The workplace /Paul F. Engelhart and Linda Barlow --Treatment for alcohol and drug dependence: history, workforce, organization, financing, and emerging policies /Dennis McCarty and Howard H. Goldman --Legal aspects of confidentiality of patient information /Margaret K. Brooks --Clinical and societal implications of drug legalization /Herbert D. Kleber and James A. Inciardi --Index.
  • Pt. 1. General principles of substance use disorders -- An initial approach -- Types of use -- The substance use disorders -- Screening techniques -- The first interview -- Outpatient logistics -- Laboratory studies -- Pt. 2. Substance review -- Alcohol -- Other sedatives -- Sedative detoxification -- Medications during sedative recovery -- Nicotine -- Stimulants -- Opiates/opioids -- Opioid detoxification -- Opioid maintenance programs -- Marijuana -- LSD -- Other drugs -- Substance-induced disorders -- Pt. 3. Substance use treatment -- Treatment settings -- Twelve step programs -- Prevention -- Who treats substance use? -- Treatment dilemmas -- Patient placement criteria -- Legal issues -- Spirituality / by Stanley E. Gitlow.
  • Tobacco. 2nd ed. 2010, OSO
    "Comprehensively covers the science and policy issues relevant to one of the major public health disasters of modern times. It pulls together the etiology and burden of the myriad of tobacco-related diseases with the successes and failures of tobacco control policies. The book looks at lessons learnt to help set health policy for reducing the burden of tobacco-related diseases. It also deals with the international public health policy issues which bear on control of the problem of tobacco use and which vary between continents."--Publisher's description
  • From the stresses of repeated deployments to the difficulties of re-entry into civilian life, we are just beginning to understand how protracted conflicts, such as those in Iraq and Afghanistan, are affecting service members. Issues such as risky health behaviors and chemical dependence raise productivity concerns as they do with all organizations, but they also have a profound impact on the safety and readiness of troops--and by extension, the military as a whole--in life-or-death situations. Understanding Military Workforce Productivity cuts through the myths and misconceptions about the health and resilience of today's active-duty armed forces. This first-of-its-kind volume presents up-to-date findings across service branches in core health areas including illness and injury, alcohol and drug abuse, tobacco use, obesity, and mental health. The short- and long-term implications discussed relate to the quality of the lives of service members and their families, the quality and preparedness of the military as a workforce, and prevention and intervention efforts.
  • This landmark new report presents the first comprehensive worldwide analysis of tobacco use and control efforts. It provides countries with a roadmap to reverse the devastating global tobacco epidemic that could kill up to one billion people by the end of this century. The report outlines the MPOWER package, a set of six key tobacco control measures that reflect and build on the WHO Framework Convention on Tobacco Control.
  • Workplace drug testing 2008, CRCnetBASE
    Introduction : drugs in the work place / Yale H. Caplan ; Marilyn A. Huestis -- Overview of the mandatory guidelines for federal workplace drug testing programs / Donna M. Bush -- The U.S. Department of Transportation's workplace testing program / Kenneth C. Edgell -- Drug testing in the nuclear power industry : the NRC fitness-for-duty rules / Theodore F. Shults -- Workplace drug testing outside the U.S. / Anya Pierce -- Analytical considerations and approaches for drugs / Daniel S. Isenschmid ; Bruce A. Goldberger -- Analytical approaches for drugs in biological matrixes other than urine / Pascal Kintz ; Marion Villain ; Vincent Cirimele -- Interpreting alternative matrix text results / Edward J. Cone ; Angele Sampson-Cone ; Marilyn A. Huestis -- Specimen validity testing / Yale H. Caplan -- The role of the medical review officer in workplace drug testing / John M. Mitchell ; Francis M. Esposito -- Legal issues in workplace drug testing / Theodore F. Shults.

Shortcut to Licensed Content

Lane Gateway to Licensed Content

  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Links” (IE7) or “Favorites Bar” (IE8, IE9) to install

Shortcut for iPhone

Lane Gateway to Licensed Content

  • Drag this button to your Safari bookmarks bar
  • Open iTunes and sync your iPhone; make sure "Sync Safari Bookmarks" under iPhone Info tab is selected
  • To invoke the bookmarklet on your iPhone, open Safari and tap the "Bookmarks" icon
  • Tap "Bookmarks Bar"
  • Tap "Lane Proxy Bookmarklet"

What is it?

This shortcut (Lane proxy bookmarklet) gives you access to resources licensed by the library even when you're not coming from a Lane or a Stanford IP address.

While we'd like Lane to be your gateway to our licensed content, we recognize that links to books, articles and journals come from a variety of different sources (Google, your email, RSS reader, etc.).

Lane Proxy Bookmarklet in the Bookmarks Bar
Up arrow

When installed, it will look your browser bookmark.

At the page you would like to proxy, click the "Lane Gateway to Licensed Content" to invoke it.

If Lane licenses that content, you'll get access as if you were on campus.

How does it work?

This shortcut (Lane proxy bookmarklet) is a combination of a browser bookmark and a JavaScript application. In other words, it's a bookmark that can be programmed to do things. The Lane proxy bookmarklet simply prepends the Lane proxy URL to the current URL in your browser.

This allows you to view the URL as though you were on campus, giving you access to materials licensed for use by the Stanford academic community.

If you're not authenticated, you'll be prompted for your SUNetID and password.

Don't see the Toolbar, Bookmarks, or Links or Favorites bar?

FireFox

From the "View" menu, select "Toolbars" & choose "Bookmarks Toolbar"

Safari

From the "View" menu, choose "Show Bookmarks Bar"

Chrome

From the "View" menu, choose "Always Show Bookmarks Bar"

Internet Explorer

IE controller bar
  • Right-click in a clear area near the browser address bar
  • In the menu, check a box next "Links" (IE7) or "Favorites" (IE8, IE9)
  • Managing IE Favorites

Caveats

This shortcut (Lane proxy bookmarklet) only works with resources Lane has licensed and configured to work with our proxy server.

If invoked on a resource we do not license and/or have not yet configured, you will see an error message:

The Lane proxy server cannot complete your request because this host has not been configured properly.

We make no attempt to configure our proxy server for every resource, only those we license and for which a Stanford IP address grants access.

Drag this button onto your browser toolbar to install.

  • Right click this button
  • Select "Add to Favorites", click "Continue" if you see a security alert
  • In "Create in" menu, select "Links" (IE7) or "Favorites Bar" (IE8, IE9) to install

Drag this button onto Safari Bookmarks bar to install.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more. Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.Provides one-click access to important clinical resources; includes evidence-based diagnosis and treatment guidelines, Books, EBM articles, Ovid MEDLINE, Drug facts and comparisons, Drug interaction facts, guidelines from National Guideline Clearinghouse, patient handouts (English and Spanish), and local content.MD consult provides access to textbooks, electronic journals, practice guidelines, drug information, and patient education handouts.A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.Provides online, full-text access to Springer's journal titles as well as journals from other publishers. Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.